Therapeutic Exosomes: From Molecular Biology to ClinicalTranslation

CURRENT MEDICINAL CHEMISTRY · Published 2026-07-25 · DOI 10.2174/0109298673506816260713102723

Authors (2)

Maxim Shkurnikov, Alexander Tonevitsky

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Shkurnikov, M., Tonevitsky, A. (2026). Therapeutic Exosomes: From Molecular Biology to ClinicalTranslation. CURRENT MEDICINAL CHEMISTRY. https://doi.org/10.2174/0109298673506816260713102723

Related articles

• EGFR Dysregulation in Cancer: From Molecular Mechanisms andKey Mutations to Evolving TKI Strategies and Resistance Mitigation · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Exploring the Therapeutic Potential of Mangiferin in Promoting Health Span and Stress Tolerance in C. elegans · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Organ Injury, Protection and Interactions: Novel Targets, Drugs,and Mechanisms · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Proteome-Wide Mendelian Randomization Identifies Novel Plasma Protein Targets in Osteoarthritis · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Causal Relationship between Obesity-related Indicators and Major PeripheralVascular Diseases: Two-sample and Multivariate MendelianRandomization Studies · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Identification of COX7B, GLRX5, and OR52H1 as VascularEndothelial Injury-associated Biomarkers in Gestational DiabetesMellitus · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Novel Insights into the Causal Effects of Plasma Protein-to-protein Ratios on Aneurysms and the Mediating Effects of Cardiometabolic Traits · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• DHRS2 as a Novel Thalidomide Target Regulating Mitophagyand Inflammation in Head and Neck Squamous Cell Carcinoma · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Biosynthesis of Nimbin and the Metabolic Pathway: A Focus on itsAntiviral Properties · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Integrating Methylation Signature Modifications and Subtype Classification into a Prognostic Risk Model for Survival Prognosis and Predicting Immunotherapy Response in Colorectal Cancer · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal